Examining patient and professional perspectives in the UK for gene therapy in haemophilia

Examining patient and professional perspectives in the UK for gene therapy in haemophilia

PubMed.gov

Image

Please enable the javascript to submit this form

Supported by educational grants from Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc.

Essential SSL